Clinical studies recruiting near Leiden

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
Phase 2/Phase 3 · The MMRd-GREEN trial: Leiden University Medical Center · Leiden University Medical Center · NCT05255653 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Leiden University Medical Center (LUMC) · Miltenyi Biomedicine GmbH · NCT04844866 A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Phase 3 · Leiden University · Vertex Pharmaceuticals Incorporated · NCT04786262 UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
Phase N/A · Willem-Alexander Children's Hospital, LUMC · The Hospital for Sick Children · NCT06560606 Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies
Phase 3 · Leids University Medical Center (LUMC) · Lakefront Biotherapeutics NV · NCT06652633 'Improving Urinary Tract Infection Diagnosis in Older Patients: Validation of a Biomarker Panel (UTI-GOLD)'
Phase N/A · Leiden university medical center (LUMC) · Leiden University Medical Center · NCT06610721 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Leids Universitair Medisch Centrum · Amgen · NCT07037433 SAR447971 First-in-human Study
Phase 1 · Investigational Site Number: 5280001 · Sanofi · NCT07629336 A Research Study Looking at the Safety of Single and Multiple Doses of ZP9830 and How it Works in the Body of Healthy Pa
Phase 1 · Centre for Human Drug Research · Zealand Pharma · NCT06682975 LEOPARD Prospective Validation Cohort 1
Phase N/A · Center for Liver Tumors Leiden of the Leiden University Medi · Assistance Publique - Hôpitaux de Paris · NCT06723275 A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
Phase 1/Phase 2 · Leiden University Medical Center LUMC · Vico Therapeutics B. V. · NCT05822908 BioClock: Bright Light Therapy for Depressive Disorders
NA · Leids Universitair Behandel- en Expertise Centrum · Universiteit Leiden · NCT05958940 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198 Adjuvant Tebentafusp in High Risk Ocular Melanoma
Phase 3 · Leiden University Medical Centre · European Organisation for Research and Treatment of Cancer - · NCT06246149 Vascular Signature Mapping of Brain Tumor Genotypes
Phase N/A · Leiden University Medical Center · Leiden University Medical Center · NCT05274919 A Trial to Understand How Safe and Well Tolerated ZP9830 is and How it Works in People With Plaque Psoriasis Over an 8-w
Phase 1 · Centre for Human Drug Research · Zealand Pharma · NCT07733089 Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer
Phase N/A · Leiden University Medical Center · Maastricht University Medical Center · NCT04486495 A Study With CIT-013 in RA Patients
Phase 2 · NL-04 · Citryll BV · NCT06567470 Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Phase 2 · Leiden Universitair Medisch Centrum (LUMC) · NMD Pharma A/S · NCT06414954 Surface Electrical Myography, Oxygen Consumption, Effort, and Weaning in the Mechanically Ventilated Patient in the Inte
Phase N/A · Leiden University Medical Centre · Leiden University Medical Center · NCT07109570 Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT03955445 KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC)
Phase 2 · Leids Universitair Medisch Centrum ( Site 0273) · Merck Sharp & Dohme LLC · NCT07252739 Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosi
Phase 3 · Leiden University Medical Center · Takeda · NCT05677971 InvaplexAR-Detox and DmLT Adjuvant in the Netherlands and Zambia
Phase 1 · Leiden University Medical Center · Leiden University Medical Center · NCT05961059 A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · Leids Universitair Medisch Center · Takeda · NCT06963827 NIR-Fluorescence Guided Surgical Resection of Neoadjuvant Treated Localized Pancreatic Cancer Using SGM-101
Phase 2 · Leiden University Medical Center · Leiden University Medical Center · NCT05984810 Study of ARO-DUX4 in Adult and Adolescent Patients With Facioscapulohumeral Muscular Dystrophy Type 1
Phase 1/Phase 2 · Research Site 1 · Arrowhead Pharmaceuticals · NCT06131983 Post-Market Clinical Follow Up Study With Navitor Valve
Phase N/A · Leiden University Medical Center · Abbott Medical Devices · NCT06008080 A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thro
Phase 3 · Leiden University Medical Center · Janssen Research & Development, LLC · NCT06533098 Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC
Phase 2 · Leids Universitair Medisch Centrum · Leiden University Medical Center · NCT05393791

Look up another city

Look up another condition